Crossing the blood-brain barrier: novel approaches for delivery of therapeutics directly to the brain

Watch this video to find out from Dr Vogelbaum how therapeutics can be delivered into the brain more effectively.

Dr. Vogelbaum has disclosed that he is/was a consultant/advisor for Celgene and Tocagen and has stock ownership of and received royalties/payments from Infuseon Therapeutics Inc.